CCND1 Gain May Not Be a Common Copy Number Aberration in Melanoma: 82 Cases with Data from Array Comparative Genomic Hybridization

Part of: Oral Abstract Session 1

Incorporating the 40-GEP Test for Poorly Differentiated Cutaneous Tumors Mitigates Risk Assessment Uncertainty Due to Histologic Grading

Sarah Estrada

Part of: Oral Abstract Session 1

Impetiginization Rates of Plaque Psoriasis Skin Lesions

Gitanjali Bhushan

Part of: Oral Abstract Session 1

Histopathologic Features of Gottron's Papules and Gottron's Sign in Dermatomyositis

Lydia Cassard

Part of: Oral Abstract Session 1

Cytokine RNA in situ Hybridization Facilitates Diagnosis of Acral Psoriasis Versus Eczema and Reveals Distinct Immunology Compared to Non-acral Sites

Part of: Oral Abstract Session 1

The Clinical and Histopathologic Spectrum of Toxic Erythema of Chemotherapy: A Series of 56 Cases from a Single Institution

Daniel Cole

Part of: Oral Abstract Session 1

Primary Cutaneous Extraskeletal Osteosarcoma: A Clinicopathologic Case Series of 16 Patients

Omar Habeeb

Part of: Oral Abstract Session 1

Clinical Validation and Utility of SNP Microarray for Molecular Characterization of Melanocytic Lesions: Diagnostics and Prognostication of Melanomas

Part of: Oral Abstract Session 1

Pre-ordering Periodic Acid-Schiff Staining: Can Clinical Differential Direct Selective Use? A Quality Improvement Study

Danielle Mustin; Zachary Wolner; Howa Yeung & Benjamin Stoff

Part of: Oral Abstract Session 1

Skin Cytokine Profiles Determined by RNA in situ Hybridization Correlate with Response to Dupilumab in Patients with Eczematous Dermatitis

Katelyn Singh

Part of: Oral Abstract Session 1

Discovery of AMBLor as an Immunohistochemical Prognostic Biomarker for Non-ulcerated AJCC Stage I/II Cutaneous Melanoma

Phil Sloan

Part of: Oral Abstract Session 1